Risk factors for decreased teicoplanin trough concentrations during initial dosing in critically ill patients.

Yoshida, T; Yoshida, S; Okada, H; Suzuki, A; Niwa, T; Suzuki, K; Ohmori, T; Kobayashi, R; Baba, H; Suzuki, K; Murakami, N; Itoh, Y; Ogura, S

Yoshida, T; Yoshida, S; Okada, H; Suzuki, A; Niwa, T; Suzuki, K; Ohmori, T; Kobayashi, R; Baba, H; Suzuki, K; Murakami, N; Itoh, Y; Ogura, S.

Pharmazie ; 74(2): 120-124, 2019 02 01.

Article in En | MEDLINE | ID: mdl-30782263

Subject(s)

Anti-Bacterial Agents/blood; Infections/blood; Infections/drug therapy; Teicoplanin/blood; Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents/administration & dosage; Critical Illness; Female; Humans; Infant; Male; Middle Aged; Retrospective Studies; Risk Factors; Teicoplanin/administration & dosage; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Teicoplanin / Infections / Anti-Bacterial Agents Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Infant / Male / Middle aged Language: En Journal: Pharmazie Journal subject: FARMACIA Year: 2019 Document type: Article Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google